Document is current
Any future updates will be listed below
-
Authors
Kayaalp Nalbant, Elif
Feliciano, Timothy J.
Mohammadlou, Aliakbar
Xiong, Vincent L.
Trujillo, Jacquelyn E.
Calvert, Andrea E.
Kaplan, Nihal
Foroozandeh, Parisa
Kim, Jayden
Bai, Emma M.
Qi, Xiaolin
Tobias, Fernando
Roth, Eric W.
Dravid, Vinayak P.
Lu, Kurt Q.
Nguyen, SonBinh T.
Shad Thaxton, C.
Peng, Han
Lavker, Robert M.
-
Funding
Funding for this research was provided by:
National Institutes of Health (T32GM008152)
National Institutes of Health (F31AR081685)
National Institues of Health Chemical Countermeasures Research Program (U54AR079795)
National Institues of Health Chemical Countermeasures Research Program (U54AR079795)
National Institues of Health Chemical Countermeasures Research Program (U54AR079795)
National Institues of Health Chemical Countermeasures Research Program (U54AR079795)
National Institues of Health Chemical Countermeasures Research Program (U54AR079795)
National Eye Institute (EY019463, EY032922, EY028560, EY036320)
National Eye Institute (EY019463, EY032922, EY028560, EY036320)
- License Information
-
More Information
Article History
Received: 30 October 2024
Accepted: 6 March 2025
First Online: 20 March 2025
Competing interests
: CST is the co-founder of a biotech company that licensed technology from Northwestern University. The remaining authors declare that they have no competing interests.
